Related Experiment Video
Updated: Aug 22, 2025

Assessment of Intestinal Transcytosis of Neonatal Escherichia coli Bacteremia Isolates
Published on: February 17, 2023
Intestinal Dominance by Multidrug-Resistant Bacteria in Pediatric Liver Transplant Patients
Elias Dahdouh1, Lorena Fernández-Tomé2, Emilio Cendejas-Bueno1
1Clinical Microbiology and Parasitology Department, Hospital Universitario La Pazgrid.81821.32, IdiPAZ, Madrid, Spain.
Abstract:
Pediatric liver transplantation (PLTx) is commonly associated with extensive antibiotic treatments that can produce gut microbiome alterations and open the way to dominance by multidrug-resistant organisms (MDROs). In this study, the relationship between intestinal Relative Loads (RLs) of β-lactamase genes, antibiotic consumption, microbiome disruption, and the extraintestinal dissemination of MDROs among PLTx patients is investigated. 28 PLTx patients were included, from whom 169 rectal swabs were collected. Total DNA was extracted and blaCTX-M-1-Family, blaOXA-1, blaOXA-48, and blaVIM were quantified via quantitative polymerase chain reaction (qPCR) and normalized to the total bacterial load (16SrRNA) through LogΔΔCt to determine the RLs. 16SrRNA sequencing was performed for 18 samples, and metagenomic sequencing was performed for 2. Patients' clinical data were retrieved from the hospital's database. At least one of the genes tested were detected in all of the patients. The RLs for blaCTX-M-1-Family, blaOXA-1, blaOXA-48, and blaVIM were higher than 1% of the total bacterial population in 67 (80.73%), 56 (78.87%), 57 (77.03%) and 39 (61.9%) samples, respectively. High RLs for blaCTX-M-1-Family, blaOXA-1, and/or blaOXA-48, were positively associated with the consumption of carbapenems with trimethoprim-sulfamethoxazole and coincided with low diversity in the gut microbiome. Low RLs were associated with the consumption of noncarbapenem β-lactams with aminoglycosides (P < 0.05). Extraintestinal isolates harboring the same gene(s) as those detected intraintestinally were found in 18 samples, and the RLs of the respective swabs were high. We demonstrated a relationship between the consumption of carbapenems with trimethoprim-sulfamethoxazole, intestinal dominance by MDROs and extraintestinal spread of these organisms among PLTx patients. IMPORTANCE In this study, we track the relative intestinal loads of antibiotic resistance genes among pediatric liver transplant patients and determine the relationship between this load, antibiotic consumption, and infections caused by antibiotic-resistant organisms. We demonstrate that the consumption of broad spectrum antibiotics increase this load and decrease the gut microbial diversity among these patients. Moreover, the high loads of resistance genes were related to the extraintestinal spread of multidrug-resistant organisms. Together, our data show that the tracking of the relative intestinal loads of antibiotic resistance genes can be used as a biomarker that has the potential to stop the extraintestinal spread of antibiotic-resistant bacteria via the measurement of the intestinal dominance of these organisms, thereby allowing for the application of preventive measures.
Insights
Extensive antibiotic use in pediatric liver transplant patients increases gut multidrug-resistant organisms (MDROs). Tracking antibiotic resistance genes in the gut can predict and prevent MDRO spread, improving patient outcomes.
Area of Science:
- Microbiology
- Transplantation
- Pharmacology
Background:
- Pediatric liver transplantation (PLTx) patients often receive extensive antibiotic therapy, leading to gut microbiome dysbiosis and the proliferation of multidrug-resistant organisms (MDROs).
- Understanding the dynamics of antibiotic resistance genes (ARGs) within the gut microbiome is crucial for managing infections in immunocompromised populations like PLTx recipients.
Purpose of the Study:
- To investigate the relationship between intestinal relative loads (RLs) of key β-lactamase genes (blaCTX-M-1-Family, blaOXA-1, blaOXA-48, blaVIM), antibiotic consumption patterns, microbiome disruption, and the extraintestinal dissemination of MDROs in PLTx patients.
- To explore the potential of gut ARG RLs as a biomarker for predicting and preventing MDRO spread in this vulnerable patient group.
Main Methods:
- Quantification of specific β-lactamase genes (blaCTX-M-1-Family, blaOXA-1, blaOXA-48, blaVIM) and the 16S rRNA gene in 169 rectal swabs from 28 PLTx patients using quantitative polymerase chain reaction (qPCR).
- Calculation of relative loads (RLs) of ARGs normalized to the total bacterial load (LogΔΔCt).
- Analysis of gut microbiome diversity via 16S rRNA sequencing (18 samples) and metagenomic sequencing (2 samples), alongside retrieval of patients' clinical and antibiotic consumption data.
Main Results:
- All patients harbored at least one of the tested β-lactamase genes, with high RLs (>1%) observed frequently for blaCTX-M-1-Family (80.73%), blaOXA-1 (78.87%), blaOXA-48 (77.03%), and blaVIM (61.9%).
- High RLs of blaCTX-M-1-Family, blaOXA-1, and/or blaOXA-48 were associated with carbapenem and trimethoprim-sulfamethoxazole consumption and reduced gut microbial diversity.
- Extraintestinal MDRO isolates with matching ARGs were found in 18 samples, correlating with high intraintestinal ARG RLs, indicating a link between gut colonization and systemic infection.
Conclusions:
- Consumption of broad-spectrum antibiotics like carbapenems with trimethoprim-sulfamethoxazole drives intestinal dominance of MDROs and increases the risk of extraintestinal spread in PLTx patients.
- Tracking intestinal ARG RLs can serve as a valuable biomarker to identify patients at high risk for MDRO dissemination.
- Monitoring gut ARG RLs allows for timely implementation of preventive strategies to curb the spread of antibiotic-resistant bacteria in vulnerable transplant populations.
Related Concept Videos
Development of Antibiotic Resistance
Kidney Transplant II: Surgical Procedure
Kidney Transplant III: Nursing Management
Kidney Transplant I: Introduction

